BiotechTube
Corentec

Corentec

San Diego, United States· Est.
corentec-usa.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $55M

Overview

Corentec is a privately-held orthopedic device company operating in the value segment of the joint replacement market, positioned between premium brands and entry-level manufacturers. Its portfolio includes the BENCOX Hip System, EXULT & LOSPA Knee Systems, and revision solutions, featuring advanced manufacturing like 3D-printed acetabular cups via Directed Energy Deposition (DED). The company emphasizes clinical evidence, surgeon education through its FiRST Academy, and global expansion, targeting cost-conscious healthcare systems without sacrificing product quality.

OrthopedicsMusculoskeletal

Technology Platform

Advanced orthopedic implant design and manufacturing, featuring Directed Energy Deposition (DED) metal 3D printing for creating porous acetabular cups that promote bone ingrowth.

Funding History

2
Total raised:$55M
Series B$40M
Series A$15M

Opportunities

The growing global demand for cost-effective, high-quality joint replacements in value-conscious healthcare systems presents a significant opportunity.
Corentec's advanced 3D printing technology (DED) serves as a key differentiator, allowing it to compete on innovation while maintaining an affordable price point, appealing to both emerging markets and cost-sensitive segments in developed countries.

Risk Factors

Corentec faces intense competition from large, established orthopedic giants with greater resources and brand loyalty.
Regulatory hurdles across different global markets and potential product liability issues associated with implant performance are persistent risks.
Additionally, the company's reliance on sophisticated manufacturing processes makes it vulnerable to supply chain disruptions.

Competitive Landscape

Corentec operates in the highly competitive orthopedic joint replacement market, dominated by multinational giants like Stryker, Zimmer Biomet, and Johnson & Johnson. Its primary competitive strategy is to occupy the value segment, competing on price and advanced features (like 3D printing) against other value players and private label manufacturers, while differentiating from premium brands on cost.

More companies in Drug Delivery & Formulation →More companies in United States →